Bristol’s 2025 Guidance Falls Short, But CEO Boerner Warned This Was Coming

$2bn In Cost Cuts Planned; Medicare Redesign Neutral

 
• By Mandy Jackson
  
BMS forecast an almost $3bn revenue decline in 2025 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip